CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Anthem Biosciences Ltd.

NSE : ANTHEMEQ BSE : 544449 ISIN CODE : INE0CZ201020Industry : Pharmaceuticals

News

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Cessation 13 Mar 2026 | 18:35 | Dion Global

    Anthem Biosciences Limited hereby informs the exchange of the resignation of Mr. K Ramakrishnan from the position of General Counsel and consequently...more...

  • Anthem Biosciences - Resignation 13 Mar 2026 | 18:31 | Dion Global

    Anthem Biosciences Limited has informed the Exchange regarding Resignation of Mr K. Ramakrishnan as Other of the company w.e.f. March 31 2026.more...

  • Anthem Biosciences - Agreements 23 Feb 2026 | 19:23 | Dion Global

    Anthem Biosciences Limited hereby informs the Exchange of the First Amendment to the Loan Agreement dated April 15 2024 entered into with Neaonathem ...more...

  • Anthem Biosciences - Analysts/Institutional Investor Meet/Con. Call Updates 09 Feb 2026 | 16:39 | Dion Global

    Anthem Biosciences Limited has informed the Exchange about Transcriptmore...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 09 Feb 2026 | 16:32 | Dion Global

    Earnings Call Transcript for Q3 FY26more...

  • Anthem Biosciences - Copy of Newspaper Publication 06 Feb 2026 | 12:58 | Dion Global

    Anthem Biosciences Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) 05 Feb 2026 | 19:39 | Dion Global

    Submission of revised press release for the quarter and nine months ended December 31 2025 in machine readable formatmore...

  • Anthem Biosciences - Press Release (Revised) 05 Feb 2026 | 19:37 | Dion Global

    Submission of Press Release for the Financial Results for the quarter and nine months ended December 31 2025 in machine readable format.more...

  • Anthem Biosciences - Analysts/Institutional Investor Meet/Con. Call Updates 05 Feb 2026 | 18:10 | Dion Global

    Submission of Audio recordings of Earnings Call for the quarter and nine months ended December 31 2025more...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 05 Feb 2026 | 18:03 | Dion Global

    Submission of audio recordings of Earnings Call for the quarter and nine months ended December 31 2025more...

  • Anthem Biosciences - General Updates 05 Feb 2026 | 14:39 | Dion Global

    Allotment of 1 03 800 equity shares of face value Rs. 2 each pursuant to the exercise of ESOP Options under Anthem Employee Stock Option Plan 2024more...

  • Anthem Biosciences Q3 net profit down 12.39% at Rs 112.13 cr 05 Feb 2026 | 14:30 | Dion Global

    The company reported standalone net profit of Rs 112.13 crore for the quarter ended December 31 2025 as compared to Rs 127.99 crore in the s...more...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 05 Feb 2026 | 14:30 | Dion Global

    Allotment of 1 03 800 equity shares of face value Rs. 2 each pursuant to the exercise of ESOP Options under Anthem Employee Stock Option Plan 2024more...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) 05 Feb 2026 | 14:26 | Dion Global

    Submission of revised Press Release for the Financial Results for the quarter and nine months ended December 31 2025 due to inadvertent miss...more...

  • Anthem Biosciences - Press Release (Revised) 05 Feb 2026 | 14:06 | Dion Global

    Revised press release for the financial results for the quarter and nine months ended December 31 2025 due to inadvertent missing out on the complete...more...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release 05 Feb 2026 | 13:48 | Dion Global

    Press release for the financial results for the quarter and nine months ended December 31 2025more...

  • Anthem Biosciences - Press Release 05 Feb 2026 | 13:45 | Dion Global

    Press release for the financial results for the quarter and nine months ended December 31 2025.more...

  • Anthem Biosciences - Investor Presentation 05 Feb 2026 | 13:36 | Dion Global

    Anthem Biosciences Limited has informed the Exchange about Investor Presentationmore...

  • Anthem Biosciences - Announcement under Regulation 30 (LODR)-Investor Presentation 05 Feb 2026 | 13:34 | Dion Global

    Submission of Investor Presentation for the quarter and nine months ended December 31 2025more...

  • Anthem Biosciences - Financial Results For The Quarter And Nine Months Ended December 31, 2025 05 Feb 2026 | 13:25 | Dion Global

    Submission of financial results for the quarter and nine months ended December 31 2025more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex73207.660.70%
NSE Index22667.90.68%
B500DIVL503316.420.15%
BSE 1000 9645.60.55%
BSE 100LCTMC8392.990.60%
BSE Auto 53283.520.58%

Commodity

Gold135846-7.36%
Silver209713-9.02%
Copper1171.4187.25%
Crude Oil827529.03%
Lead191.6542.60%
Mentha Oil1103.83.41%
Nickel1584.2106.57%

Currency

USD/INR 93.35(0.97 %)
GBP/INR 125.16(1.23 %)
EUR/INR 107.94(1.10 %)
JPY/INR 0.59(1.21 %)
CAD/INR 67.34(0.00 %)
HKD/INR 11.80(0.02 %)